semaglutide hfref and NT-proBNP in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program Efficacy and safety of semaglutide

J Chronic Fatigue Syndr

17 In a long-term randomized, double-blind, factorial trial, the efficacy and safety of sitagliptin/metformin were assessed in type-2 diabetes patients with inadequately controlled blood glucose levels

Semaglutide is an FDA-approved GLP-1 receptor agonist originally developed for type 2 diabetes management that has also been approved for chronic weight management under the brand name Semaglutide (GLP-1 weight loss)

The digestive challenges are similar to other gut issues, and these proven strategies for beating bloat and improving digestion can provide additional relief when combined with medication-specific approaches